Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1CNS 1

Conditions

Recurrence 1Medulloblastoma 1Carcinoma, Basal Cell 1

Interventions

sonidegib 2Etoposide 2Carboplatin 2tipifarnib 1merphos 1entinostat 1carboxyamido-triazole 1bempegaldesleukin 1Vincristine 1Thrombopoietin 1Thalidomide 1Paclitaxel 1Oxaliplatin 1Nivolumab 1NVP-LEQ506 1Methotrexate 1Mental Status and Dementia Tests 1LY2940680 1Irinotecan 1Immunologic Techniques 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Fentanyl 1Docetaxel 1Cyclophosphamide 190Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Medulloblastoma × NVP-LEQ506 × Dermatologic × Clear all
NCT01106508 2020-12-17

A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors

Novartis

Phase 1 Completed
57 enrolled
CNSDermatologic

Carcinoma, Basal Cell, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡